Dynavax stock rises after hepatitis B vaccine recommendation by CDC immunization committee

Dynavax stock rises after hepatitis B vaccine recommendation by CDC immunization committee  MarketWatch News of Note—AstraZeneca's FluMist, Dynavax's Heplisav-B head to ACIP  FiercePharma Dynavax's HEPLISAV-B™ [Hepatitis B Vaccine (Recombinant), Adjuvanted] Recommended by CDC Advisory ...  GlobeNewswire (press release)Full coverage

Read More ...
Dynavax stock rises after hepatitis B vaccine recommendation by CDC immunization committee published February 21, 2018 at 10:04PM. Original Source Link : https://www.marketwatch.com/story/dynavax-stock-rises-after-hepatitis-b-vaccine-recommendation-by-cdc-immunization-committee-2018-02-21-1091444

loading...